Premium
Presymptomatic testing for myotonic dystrophy by means of the linked DNA marker APOC2
Author(s) -
Haan Eric A.,
Mulley John C.,
Gedeon Agi K.,
Sutherland Grant R.,
Sheffield Leslie J.
Publication year - 1988
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1988.tb120637.x
Subject(s) - myotonic dystrophy , genetics , gene , genetic linkage , biology , genetic marker , penetrance , phenotype
A family in which the gene for myotonic dystrophy is segregating was tested with a DNA probe to the apolipoprotein‐C2 (APOC2) gene. The APOC2 gene is linked closely to the myotonic dystrophy ( DM) gene and can be used as a marker to follow the transmission of the DM gene within families. Results from DNA‐marker studies were combined with information from clinical, ophthalmological and electromyographic examinations, with age‐dependent penetrance and a recombinant frequency of 4% between the genes for myotonic dystrophy and apolipoprotein C2 being taken into account. The chance that an individual had inherited the gene for myotonic dystrophy was determined by means of the computer program, LINKAGE. This analysis altered dramatically the assessed risk that certain individuals in the family were carrying the DM gene. For four individuals in the family, the previous risks of 50% for each member were reduced to 0.9%, 0.9% and 0.2%, respectively, in three cases and increased to 91% in the fourth case. The importance of a complete clinical evaluation of potential gene carriers who donate blood for a DNA‐linkage study is stressed.